Although medical mycology is recognized by its practitioners as an independent area of professional commitment, its roots can be traced to a broad range of medical and biological disciplines. It incorporates elements from such diverse fields as dermatology, genetics, pathology and histopathology, infectious disease, veterinary medicine, mycology, immunology, microbiology, epidemiology, and more recently, cellular and molecular biology. It follows that the term "medical mycologist" is an imprecise one, and does not adequately indicate origins and spheres of interest of those who work in the field.
Medical mycology is perhaps best viewed as a mosaic rather than an amalgam, the cement which binds its component parts together being mycology itself. It is an interest in the fungi, their products and their activities which constitutes the single unifying element that links medical mycologists and their endeavours throughout the world.
In this presentation, I wish to concentrate on medical mycology as it is today. The history of its development is of equal relevance to an understanding of the subject is the history of its development, but I propose to explore this topic more fully in my Presidential Address at the 11th ISHAM Congress in Montreal next year.
Medical Mycology : International Aspects
The spectrum of medical mycology today varies considerably from country to country. To some extent, the International Society for Human and Animal Mycology (ISHAM) reflects the interest taken in medically important fungi and their associated diseases throughout the world. The reflected image is an imperfect one, for in some countries, financial regulations, administrative complications, low salaries, and difficulties of communication, including those related to language, may conspire to make membership impracticable.
Nevertheless, a study of the ISHAM membership shows several interesting and revealing features.
The Society has 840 members from 68 coun-tries (Table 1) . The United States, with 231 members has the biggest membership (27.5%) . Japan has 80 members (9.5%), followed by the United Kingdom with 55, and the combined Germanies with 52. These four countries account for almost 50% of the Society's total membership.
Predictably, distribution of the membership is uneven : thus, 41 (80%) of the 68 countries have fewer than five members, and 27 (40%) fewer than three. Tropical countries account for 29 (43%) of the total number of countries, but only 15% of the total membership. Not surprisingly , membership from countries where English is spoken as a first language is high, 40% of the total being in this category.
When distribution figures are viewed in terms of the regions defined by the World Health Organization, startling inequities become evident (Table 2) .
Thus only nine members are located in Africa (1%), 16 from the East Mediterranean (2%), and 25 from SE Asia (3%). The West Pacific (which includes Japan) accounts for 15% of the membership, with Europe and the Americas 40% each. Only 65 of 126 WHO States (51.6 %) have ISHAM members.
There is only one member from China and three from the Soviet Union. There are none from Kenya, Jamaica, the Phillipines, Burma, Papua New Guinea, and many other parts of the globe where mycoses are known to constitute an important public health problem. ISHAM therefore represents only a proportion of the world's mycological community. Regional interests are sometimes served by national and other international societies ( Table 3 ).
The Japanese Society for Medical Mycology is one of 19 organizations formally affiliated with ISHAM. With more than 900 members, it is larger than ISHAM itself, and arguably the most vigorous of all national mycopathological societies. It is to such Societies that ISHAM looks for regional leadership and for productive interaction in the international forum.
Other international organizations providing some support for medical mycology include the International Union of Microbiological Societies (IUMS), and the International Mycological Association (IMA). The IUMS has an active Mycology Division, which promotes interest in mycopathology at IUMS Congress, and by organizing occasional training Courses.
Programmes for both the IUMS Congress in Osaka, and the IMA Congress in Germany included sessions on medical mycology. The IMA Congresses are the biggest international meetings devoted to mycology. The 1990 Congress in Regensburg attracted more than 1600 my-cologists. The largest Congresses devoted to medical mycology, however, are those organized by ISHAM. The number of participants expected to attend the Society's 11th Congress in Montreal may exceed 1,000.
Medical mycology : the world literature
The world's scientific literature provides a direct expression and measure of current interest in medical mycology. Papers may be published in journals specializing in medical mycology, or in a large number and range of other medical and biological periodicals. Monographs, reviews manuals and textbooks are more abundant now than ever before.
An analysis of more than 3,000 abstracts published in the Review of Medical and Veterinary Mycology during the past year (Table 4) , shows that almost 24% of papers selected for inclusion were concerned with mycotoxins and mycotoxicoses. An additional 31 % dealt with candidosis and antifungals. A survey of papers published during 1989 in the Japanese Journal for Medical Mycology shows that the range of interests is a wide one, without any single theme predominating. The topics closely resemble those appearing in the Bulletin of the Societe francais de Mycologie medical (Table 6 ).
Medical mycology : the status quo
Much present-day attention focuses on diagnosis and treatment of mycoses, and on features and qualities of the fungal cell often in the context of antigenic or biochemical studies which may be applied to serological or immunopathological aspects of infection. A more recent interest is the study of genotypic or phenotypic characteristics which can be used for epidemiological studies. Molecular biology is providing new tools, approaches and perspectives, but their full impact on medical mycology has yet to be felt.
For those whose primary responsibilities are clinical, interest in the fungi is often indirect rather than direct, being concerned not with fungal biology but with diagnosis and management of mycoses as infectious diseases. Such individuals may be described as elective rather than career mycologists. As a rule, these correspond to part-time and full-time commitments respectively. These are not intended to be pejorative terms, and it may be noted that most members of ISHAM and its affiliated societies are in this category.
Their contributions to diagnosis, therapy, immunology, pathology, and epidemiology, are crucial to the viability and advancement of medical mycology, but progress in fundamental tance today for the future well-being, vigour, productivity, and perhaps even the continued existence of medical mycology as an independent subject.
There has been a tendency over the past few years for medical mycology to become separated into its component parts, and for independent units to assume responsibility for what are often highly specialized areas of involvement. This is particularly evident in clinical mycology where new laboratory diagnostic procedures or chemotherapeutic agents are being assessed in a hospital environment. This is undoubtedly the most appropriate location for such activities, but fragmentation of medical mycology, or sometimes its incorporation into other medical disciplines as a matter of organizational convenience or economic necessity, could have far-reaching and partially harmful effects on the future of the subject. These effects may not be immediately apparent, but financial and administrative expediency and altered priorities may contribute to a steep decline of interest in fungal biology and in the vital role played by the medical mycologist in maintaining the fabric and integrity of the subject.
Isolation is a fore-runner of decline, and the importance of such meetings as the present one, together with the positive influence of national and international societies in promoting and sustaining interest in the subject cannot be over-emphasized.
The particular quality of individual mycology units throughout the world depends on the combination of location, primary field of interest, and the background and special interests of the individual scientists comprising the group. Comparison of groups in different parts of the world shows very wide differences in their nature, primary responsibilities and activities, and in their funding, productivity and influence.
Mycology units originate because specific needs have arisen which are sufficiently compelling to justify their formation. These units will be increasingly entrusted to competent bench technicians, probably working part-time, but who are skilled with the use of basic test procedures, including commercial kits. I believe the reduced dependency on career mycologists will continue, and that this loss of mycological capability will inevitably lead to a loss of cohesion of the subject, and a lack of continuity in existing medical mycology units. This is a challenging time for professional mycologists. If their future role is confined to identification of rare or unfamiliar isolates, they may find themselves increasingly distanced from the clinical interface, and its key areas, diagnosis and management.
It is my belief that if medical mycology is to continue into the next millenium as a discipline in its own right, careful and constructive thought must be given to its future role. Mycological competence will be required as long as the spectrum of opportunistic fungal pathogens continues to expand. I am not advocating opposition to change. On the contrary, innovations are an essential component of progress.
It is nevertheless important to ensure as far as possible that changes do not happen without awareness and approval of their occurrence and consequences.
Medical mycology is more vigorous in some countries than in others. This may have little or no relationship to numbers of members of national or international societies. For example, Thailand or Latin America as a whole may not appear prominently in membership lists of international professional societies, but mycoses are important public health problems there as elsewhere, and substantial numbers of mycologists are currently employed in diagnostic, investigative and educational capacities in these parts of the world.
Medical mycology appears to be more stable in some countries than in others. Where it has been based on traditional (botanical) origins, the decline has been most marked. Fungal taxonomy today has few devotees and minimal career opportunities.
A knowledge of classific- 
Education
Mycology is not a primary profession, in the sense that it is not available as a degree course. Basic and applied mycology is taught at a variety of levels and to varying degrees at both undergraduate and postdoctoral levels, and on many medical and science courses. It achieves greatest prominence as a component of university courses in Plant Pathology and Industrial Mycology. Courses in mycological taxonomy are almost non-existent now, and training in this area is largely confined to major Culture Collections.
In 1986, ISHAM compiled the first edition of an International Register, listing courses where training in mycology can be obtained throughout the world. Copies were lodged with the WHO in Geneva. This first edition was very incomplete: it was limited to 93 entries from 33 countries, and contained only two contributions from Japan. I would urge that this International
Register should be revised, through the active cooperation of all 20 national and international organizations currently or prospectively affiliated to ISHAM.
As the number of professional mycological medical mycologists diminishes, the number and perhaps quality of courses on orthodox mycology is also becoming increasingly reduced. If medical mycology is to maintain its identity, consideration must be given to the continued provision of educational opportu-nities. It is in this area that I believe the greatest need and potential exists for fruitful cooperation between the international community.
It is not my mission to call for the conservation of classical mycology, to put back the clock, and to resume the widespread teaching of taxonomic mycology in undergraduate courses. If I have a recognizable mission, it is to seek recognition for the continuing need for Education. This is where the future of mycology lies, and this is where all existing mycologists, elective and career alike, can help, by appreciating the reality of current needs and responding to them. I am certain that ISHAM has enormous potential as a source of educators, and that it could play a decisive role in future training of basic, clinical, molecular, veterinary and other forms of mycology.
Recognition of the continuing need for Education is crucial to the survival of medical mycology as a coherent discipline. For those seeking special training and knowledge, courses and workshops, books, manuals and journals, will continue to be the mainstays of educational programmes.
However, it will also be necessary to explain its continuing need clearly and convincingly to those whose support is necessary for its survival. This includes senior governmental health officials, university administrators and educators, and appropriate international agencies. There is little doubt that medical mycology could benefit greatly by making its presence known and its importance better understood, to those concerned with delineation of health priorities and apportionment of funds. Much that is innovative is originating in the fields of molecular biology and immunology. New methodologies are becoming available, and new concepts are emerging. We can now reinvestigate and reappraise old problems with newly forged tools. It is an exciting time: one of discovery and change. Above all, it is a time to appreciate the need for collaborative thought and action, and the benefits which this would bring.
Conclusions
The climate has never been more suitable for communication and cooperation than it is today. The benefits of joint scientific investigation are clear from the most cursory of examinations of the scientific literature.
All research laboratories have their own primary fields of interest, which can occupy their attention full-time. There are nevertheless opportunities recognizable today, as never before, for the imaginative creation of approaches involving the joint skills of different centres, through the formation of specific research projects or working groups.
National Societies might find it to their advantage to consider regional manpower and training needs, production of technical manuals detailing methodologies for serological tests, antifungal assays, DNA studies and coordinated clinical trials.
Consideration might also be given to workshops or even the formation of Working Groups on specific topics, such as Cell Wall Biology, Candida or Aspergillus biology, Cryptococcosis, or Opportunistic fungi. Productive collaboration is both stimulating and rewarding. Cross-discipline interaction is needed more now than ever before. The list of potentially productive topics is endless.
The future is in your hands. Medical Mycology is in a state of flux. You are creators of its identity, the custodians of its present and the architects of its future. I do not fear for the subject here as I do elsewhere. Meetings such as the joint Japan-China Conference in Xian during 1987, and the successful Chiba. University Symposia are a tribute to the imagination and enthusiasm of those involved in their organization, and precedents for other national Societies to emulate. May the future of your Society and its associated activities continue with unbated vigour and success.
